Aleix Prat Selected Research

Aleix Prat Research Topics

Disease

151	Breast Neoplasms (Breast Cancer) 04/2024 - 06/2007
136	Neoplasms (Cancer) 05/2024 - 06/2007
19	Neoplasm Metastasis (Metastasis) 03/2024 - 11/2007
18	Triple Negative Breast Neoplasms 11/2022 - 04/2012
14	COVID-19 01/2024 - 07/2020
12	Pathologic Complete Response 04/2024 - 09/2013
9	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 04/2014
8	Disease Progression 12/2023 - 05/2008
5	Melanoma (Melanoma, Malignant) 08/2020 - 01/2016
4	Carcinoma (Carcinomatosis) 01/2022 - 12/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 11/2009
3	Neutropenia 11/2023 - 01/2020
3	Brain Neoplasms (Brain Tumor) 09/2023 - 01/2011
3	Hypoxia (Hypoxemia) 06/2021 - 04/2012
3	Residual Neoplasm 08/2020 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 01/2023
2	Infections 11/2022 - 01/2022
2	Fatigue 10/2022 - 01/2021
2	Death (Near-Death Experience) 01/2021 - 01/2018
2	Lung Neoplasms (Lung Cancer) 04/2020 - 01/2018
2	Circulating Neoplastic Cells 01/2020 - 01/2020
2	Exanthema (Rash) 01/2019 - 11/2009
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 02/2016
2	Glioblastoma (Glioblastoma Multiforme) 11/2017 - 02/2012

Drug/Important Bio-Agent (IBA)

55	Hormones (Hormone)IBA 05/2024 - 09/2008
49	Phenobarbital (Luminal)FDA Link 05/2024 - 01/2010
40	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2009
33	Trastuzumab (Herceptin)FDA Link 04/2024 - 05/2008
18	Estrogen ReceptorsIBA 10/2023 - 01/2010
15	human ERBB2 proteinIBA 04/2024 - 09/2008
14	RNA (Ribonucleic Acid)IBA 03/2024 - 09/2013
14	ClaudinsIBA 12/2015 - 01/2010
12	Docetaxel (Taxotere)FDA Link 04/2024 - 11/2016
12	ErbB Receptors (EGF Receptor)IBA 12/2023 - 09/2008
12	Messenger RNA (mRNA)IBA 06/2023 - 09/2015
11	pertuzumabIBA 04/2024 - 01/2019
11	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2016
11	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2012
9	Lapatinib (GW572016)FDA Link 01/2023 - 02/2014
8	Letrozole (Femara)FDA LinkGeneric 03/2024 - 06/2011
8	AnthracyclinesIBA 01/2023 - 04/2013
8	Taxoids (Taxanes)IBA 10/2022 - 11/2016
7	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 02/2017
7	ribociclibIBA 03/2024 - 01/2020
7	taxaneIBA 11/2020 - 09/2013
6	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2013
6	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2021
6	ParaffinIBA 01/2023 - 01/2014
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 04/2013
6	Formaldehyde (Formol)FDA Link 01/2023 - 01/2014
6	Fulvestrant (Faslodex)FDA Link 01/2022 - 10/2013
5	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
5	palbociclibIBA 12/2023 - 11/2020
5	trastuzumab deruxtecanIBA 10/2023 - 10/2021
5	AlpelisibIBA 01/2022 - 04/2015
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2010
4	Aromatase InhibitorsIBA 10/2023 - 06/2011
4	Ado-Trastuzumab EmtansineIBA 01/2023 - 07/2020
4	Estrogens (Estrogen)FDA Link 01/2023 - 09/2008
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022 - 11/2012
4	Androgen Receptors (Androgen Receptor)IBA 10/2021 - 04/2014
4	exemestane (Aromasin)FDA Link 01/2021 - 06/2011
4	Phosphotransferases (Kinase)IBA 01/2018 - 10/2013
3	AndrogensIBA 03/2024 - 04/2014
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2024 - 01/2020
3	Anastrozole (Arimidex)FDA LinkGeneric 12/2023 - 06/2011
3	atezolizumabIBA 10/2022 - 08/2020
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2022 - 01/2017
3	eribulin FDA Link 11/2021 - 01/2021
3	Everolimus FDA Link 01/2021 - 01/2019
3	pembrolizumabIBA 01/2021 - 01/2016
3	Interleukin-11 (Interleukin 11)IBA 02/2017 - 01/2013
3	IpilimumabIBA 12/2016 - 01/2016
2	Immunoglobulin G (IgG)IBA 03/2024 - 01/2023
2	COVID-19 VaccinesIBA 01/2024 - 01/2022
2	NivolumabIBA 12/2023 - 01/2017
2	Cyclin-Dependent Kinase 4IBA 12/2023 - 01/2021
2	Epidermal Growth Factor (EGF)IBA 12/2023 - 10/2019
2	Tumor Biomarkers (Tumor Markers)IBA 11/2023 - 01/2023
2	Circulating Tumor DNAIBA 01/2023 - 02/2021
2	Monoclonal AntibodiesIBA 11/2022 - 09/2008
2	AntibodiesIBA 10/2022 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2016
2	Tamoxifen FDA LinkGeneric 02/2021 - 01/2013
2	CytokinesIBA 01/2021 - 10/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2016
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2021
2	NVP-BKM120IBA 11/2020 - 11/2012
2	LigandsIBA 01/2020 - 10/2013
2	olaparibIBA 12/2019 - 11/2012
2	MicroRNAs (MicroRNA)IBA 02/2017 - 01/2013
2	Programmed Cell Death 1 ReceptorIBA 01/2017 - 01/2016

Therapy/Procedure

109	Therapeutics 04/2024 - 06/2007
48	Drug Therapy (Chemotherapy) 04/2024 - 06/2007
20	Neoadjuvant Therapy 04/2024 - 12/2015
8	Castration 03/2024 - 11/2016
7	Immunotherapy 06/2023 - 01/2020
4	Radiotherapy 11/2023 - 06/2007
3	Adjuvant Chemotherapy 02/2023 - 01/2016
2	Palliative Care (Palliative Therapy) 01/2021 - 01/2018